Responses
Regular and young investigator award abstracts
Novel single-agent immunotherapies
705 Anti-tumor activity of CB-668, a potent, selective and orally bioavailable small-molecule inhibitor of the immuno-suppressive enzyme Interleukin 4 (IL-4)-Induced Gene 1 (IL4I1)
Compose a Response to This Article
Other responses
No responses have been published for this article.
